Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Theranostics
|
April 11, 2022
Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entry
Peiyu Wang, Renwu Zhou, Rusen Zhou, et al.
International Immunopharmacology
|
August 31, 2025
Brucella-infected macrophage-derived Exosomes enhance the anti-Brucella acquired immune response
Yuting Zhang, Jing Yuan, Aodi Wu, et al.
Frontiers in Microbiology
|
December 11, 2023
SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
Romal Stewart, Kexin Yan, Sevannah A Ellis, et al.
Veterinary Microbiology
|
February 10, 2026
Brucella-infected macrophage-derived microparticles enhance the host anti-Brucella acquired immune response
Yuting Zhang, Jing Yuan, Aodi Wu, et al.
Nature Communications
|
March 28, 2018
A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses
Natalie A Prow, Liang Liu, Eri Nakayama, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 19, 2024
Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivo
Tessy A H Hick, Corinne Geertsema, Wilson Nguyen, et al.
Plos Pathogens
|
July 26, 2021
Neuroinvasiveness of the MR766 strain of Zika virus in IFNAR-/- mice maps to prM residues conserved amongst African genotype viruses
Eri Nakayama, Fumihiro Kato, Shigeru Tajima, et al.
Cell Discovery
|
May 25, 2021
Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication
Wen Juan Tu, Robert D McCuaig, Michelle Melino, et al.
NPJ Vaccines
|
July 31, 2024
A chimeric vaccine derived from Australian genotype IV Japanese encephalitis virus protects mice from lethal challenge
Jessica J Harrison, Wilson Nguyen, Mahali S Morgan, et al.
Viruses
|
January 21, 2023
Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern
Mahali S Morgan, Kexin Yan, Thuy T Le, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Theranostics
|
April 11, 2022
Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entry
Peiyu Wang, Renwu Zhou, Rusen Zhou, et al.
International Immunopharmacology
|
August 31, 2025
Brucella-infected macrophage-derived Exosomes enhance the anti-Brucella acquired immune response
Yuting Zhang, Jing Yuan, Aodi Wu, et al.
Frontiers in Microbiology
|
December 11, 2023
SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
Romal Stewart, Kexin Yan, Sevannah A Ellis, et al.
Veterinary Microbiology
|
February 10, 2026
Brucella-infected macrophage-derived microparticles enhance the host anti-Brucella acquired immune response
Yuting Zhang, Jing Yuan, Aodi Wu, et al.
Nature Communications
|
March 28, 2018
A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses
Natalie A Prow, Liang Liu, Eri Nakayama, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 19, 2024
Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivo
Tessy A H Hick, Corinne Geertsema, Wilson Nguyen, et al.
Plos Pathogens
|
July 26, 2021
Neuroinvasiveness of the MR766 strain of Zika virus in IFNAR-/- mice maps to prM residues conserved amongst African genotype viruses
Eri Nakayama, Fumihiro Kato, Shigeru Tajima, et al.
Cell Discovery
|
May 25, 2021
Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication
Wen Juan Tu, Robert D McCuaig, Michelle Melino, et al.
NPJ Vaccines
|
July 31, 2024
A chimeric vaccine derived from Australian genotype IV Japanese encephalitis virus protects mice from lethal challenge
Jessica J Harrison, Wilson Nguyen, Mahali S Morgan, et al.
Viruses
|
January 21, 2023
Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern
Mahali S Morgan, Kexin Yan, Thuy T Le, et al.
Page
of 10